Insmed Inc Stock Alpha and Beta Analysis

INSM Stock  USD 26.18  0.03  0.11%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Insmed Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Insmed over a specified time horizon. Remember, high Insmed's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Insmed's market risk premium analysis include:
Beta
1.61
Alpha
(0.18)
Risk
2.33
Sharpe Ratio
(0.03)
Expected Return
(0.08)
Please note that although Insmed alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Insmed did 0.18  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Insmed Inc stock's relative risk over its benchmark. Insmed Inc has a beta of 1.61  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Insmed will likely underperform. As of the 18th of April 2024, Book Value Per Share is likely to grow to -2.25. In addition to that, Tangible Book Value Per Share is likely to grow to -3.6.

Enterprise Value

425.35 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Insmed Backtesting, Insmed Valuation, Insmed Correlation, Insmed Hype Analysis, Insmed Volatility, Insmed History and analyze Insmed Performance.

Insmed Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Insmed market risk premium is the additional return an investor will receive from holding Insmed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Insmed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Insmed's performance over market.
α-0.18   β1.61

Insmed expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Insmed's Buy-and-hold return. Our buy-and-hold chart shows how Insmed performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Insmed Market Price Analysis

Market price analysis indicators help investors to evaluate how Insmed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Insmed shares will generate the highest return on investment. By understating and applying Insmed stock market price indicators, traders can identify Insmed position entry and exit signals to maximize returns.

Insmed Return and Market Media

The median price of Insmed for the period between Fri, Jan 19, 2024 and Thu, Apr 18, 2024 is 27.82 with a coefficient of variation of 3.23. The daily time series for the period is distributed with a sample standard deviation of 0.9, arithmetic mean of 27.72, and mean deviation of 0.73. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
E Fund Management Co. Ltd. Sells 5,905 Shares of Insmed Incorporated
02/16/2024
2
UBS initiates Insmed coverage with buy, sets 46 stock target
02/26/2024
3
Acquisition by Melvin Sharoky of 1200 shares of Insmed subject to Rule 16b-3
02/28/2024
4
FY2024 EPS Estimates for Insmed Incorporated Lowered by Cantor Fitzgerald - AmericanBankingNEWS
03/01/2024
5
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635
03/05/2024
6
California State Teachers Retirement System Cuts Position in Insmed Incorporated - Defense World
03/11/2024
7
Graham Capital Management L.P. Purchases 33969 Shares of Insmed Incorporated - Defense World
03/14/2024
8
Acquisition by Michael Smith of 58260 shares of Insmed at 29.13 subject to Rule 16b-3
04/02/2024
9
Arizona State Retirement System Sells 657 Shares of Insmed Incorporated - Defense World
04/16/2024

About Insmed Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Insmed or other stocks. Alpha measures the amount that position in Insmed Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Graham Number17.877.9316.8533.28
Receivables Turnover7.748.267.417.04

Insmed Upcoming Company Events

As portrayed in its financial statements, the presentation of Insmed's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Insmed's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Insmed's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Insmed. Please utilize our Beneish M Score to check the likelihood of Insmed's management manipulating its earnings.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Insmed

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Insmed Backtesting, Insmed Valuation, Insmed Correlation, Insmed Hype Analysis, Insmed Volatility, Insmed History and analyze Insmed Performance.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Insmed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Insmed technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Insmed trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...